Eric Joseph
Stock Analyst at JP Morgan
(2.06)
# 2,893
Out of 4,761 analysts
128
Total ratings
41.25%
Success rate
-7.82%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PLRX Pliant Therapeutics | Downgrades: Neutral | n/a | $3.08 | - | 4 | Feb 10, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Overweight | $31 → $30 | $16.87 | +77.83% | 7 | Jan 29, 2025 | |
| IGMS IGM Biosciences | Upgrades: Neutral | n/a | $1.38 | - | 8 | Jan 13, 2025 | |
| VIR Vir Biotechnology | Maintains: Neutral | $10 → $14 | $9.57 | +46.29% | 5 | Jan 9, 2025 | |
| RVMD Revolution Medicines | Maintains: Overweight | $63 → $71 | $41.34 | +71.75% | 6 | Dec 3, 2024 | |
| TGTX TG Therapeutics | Maintains: Overweight | $30 → $43 | $30.88 | +39.25% | 4 | Nov 25, 2024 | |
| PTCT PTC Therapeutics | Maintains: Overweight | $51 → $62 | $50.69 | +22.31% | 6 | Nov 19, 2024 | |
| SEPN Septerna | Initiates: Overweight | $38 | $5.80 | +555.17% | 1 | Nov 19, 2024 | |
| CAMP Camp4 Therapeutics | Initiates: Overweight | $23 | $4.81 | +378.17% | 1 | Nov 5, 2024 | |
| WVE Wave Life Sciences | Maintains: Overweight | $13 → $17 | $11.13 | +52.74% | 2 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $23 → $21 | $3.92 | +435.71% | 5 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.08 | - | 2 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $9 | $7.99 | +12.64% | 7 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $48 | $30.43 | +57.74% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $11 → $10 | $8.03 | +24.53% | 4 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $54 | $10.47 | +415.76% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.83 | - | 4 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $15 | $2.97 | +405.90% | 4 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $15 | $3.46 | +333.53% | 1 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 → $47 | $36.81 | +27.68% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 | $3.01 | +99.34% | 4 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $10 | $9.28 | +7.76% | 2 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $11 | $6.22 | +76.85% | 2 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $41 | $51.84 | -20.91% | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $5 | $0.70 | +613.57% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $5 | $0.73 | +584.84% | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.09 | - | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $4.01 | +174.66% | 6 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $11.20 | - | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $8 | $0.60 | +1,236.90% | 2 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $750 → $300 | $18.63 | +1,510.31% | 2 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $9.18 | - | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $50 | $7.28 | +586.81% | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $11 | $1.38 | +697.10% | 1 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $24 → $9 | $1.95 | +361.54% | 2 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.80 | - | 4 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $42 | $2.16 | +1,844.44% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $11 → $13 | $1.82 | +616.25% | 2 | Jan 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $11 | $1.07 | +928.04% | 3 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.68 | - | 3 | Mar 2, 2018 |
Pliant Therapeutics
Feb 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.08
Upside: -
Nurix Therapeutics
Jan 29, 2025
Maintains: Overweight
Price Target: $31 → $30
Current: $16.87
Upside: +77.83%
IGM Biosciences
Jan 13, 2025
Upgrades: Neutral
Price Target: n/a
Current: $1.38
Upside: -
Vir Biotechnology
Jan 9, 2025
Maintains: Neutral
Price Target: $10 → $14
Current: $9.57
Upside: +46.29%
Revolution Medicines
Dec 3, 2024
Maintains: Overweight
Price Target: $63 → $71
Current: $41.34
Upside: +71.75%
TG Therapeutics
Nov 25, 2024
Maintains: Overweight
Price Target: $30 → $43
Current: $30.88
Upside: +39.25%
PTC Therapeutics
Nov 19, 2024
Maintains: Overweight
Price Target: $51 → $62
Current: $50.69
Upside: +22.31%
Septerna
Nov 19, 2024
Initiates: Overweight
Price Target: $38
Current: $5.80
Upside: +555.17%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Overweight
Price Target: $23
Current: $4.81
Upside: +378.17%
Wave Life Sciences
Oct 17, 2024
Maintains: Overweight
Price Target: $13 → $17
Current: $11.13
Upside: +52.74%
Sep 10, 2024
Maintains: Overweight
Price Target: $23 → $21
Current: $3.92
Upside: +435.71%
Aug 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.08
Upside: -
Aug 12, 2024
Maintains: Underweight
Price Target: $8 → $9
Current: $7.99
Upside: +12.64%
Aug 7, 2024
Maintains: Overweight
Price Target: $45 → $48
Current: $30.43
Upside: +57.74%
Aug 6, 2024
Maintains: Underweight
Price Target: $11 → $10
Current: $8.03
Upside: +24.53%
Aug 6, 2024
Maintains: Overweight
Price Target: $50 → $54
Current: $10.47
Upside: +415.76%
Jul 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.83
Upside: -
May 13, 2024
Maintains: Overweight
Price Target: $16 → $15
Current: $2.97
Upside: +405.90%
May 3, 2024
Maintains: Neutral
Price Target: $14 → $15
Current: $3.46
Upside: +333.53%
Feb 23, 2024
Maintains: Overweight
Price Target: $34 → $47
Current: $36.81
Upside: +27.68%
Jan 29, 2024
Upgrades: Neutral
Price Target: $6
Current: $3.01
Upside: +99.34%
Nov 13, 2023
Maintains: Neutral
Price Target: $11 → $10
Current: $9.28
Upside: +7.76%
Oct 19, 2023
Maintains: Overweight
Price Target: $31 → $11
Current: $6.22
Upside: +76.85%
Oct 11, 2023
Maintains: Overweight
Price Target: $62 → $41
Current: $51.84
Upside: -20.91%
Aug 28, 2023
Downgrades: Neutral
Price Target: $15 → $5
Current: $0.70
Upside: +613.57%
Aug 28, 2023
Downgrades: Neutral
Price Target: $28 → $5
Current: $0.73
Upside: +584.84%
Aug 10, 2023
Downgrades: Underweight
Price Target: n/a
Current: $3.09
Upside: -
Aug 9, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $4.01
Upside: +174.66%
Nov 29, 2022
Downgrades: Underweight
Price Target: n/a
Current: $11.20
Upside: -
Feb 9, 2022
Upgrades: Neutral
Price Target: $8
Current: $0.60
Upside: +1,236.90%
Jan 7, 2022
Downgrades: Neutral
Price Target: $750 → $300
Current: $18.63
Upside: +1,510.31%
Oct 8, 2021
Downgrades: Underweight
Price Target: n/a
Current: $9.18
Upside: -
Jul 12, 2021
Initiates: Neutral
Price Target: $50
Current: $7.28
Upside: +586.81%
Apr 26, 2021
Initiates: Underweight
Price Target: $11
Current: $1.38
Upside: +697.10%
Jan 29, 2021
Downgrades: Neutral
Price Target: $24 → $9
Current: $1.95
Upside: +361.54%
Jan 29, 2021
Downgrades: Underweight
Price Target: n/a
Current: $1.80
Upside: -
Feb 24, 2020
Initiates: Overweight
Price Target: $42
Current: $2.16
Upside: +1,844.44%
Jan 24, 2019
Upgrades: Neutral
Price Target: $11 → $13
Current: $1.82
Upside: +616.25%
Nov 14, 2018
Maintains: Neutral
Price Target: $35 → $11
Current: $1.07
Upside: +928.04%
Mar 2, 2018
Downgrades: Underweight
Price Target: n/a
Current: $1.68
Upside: -